[Inhibition of lipolysis in adipose tissue by methylisoxazolcarboxylic acids].
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D002110:Caffeine / Q000037:antagonists & inhibitors; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D005227:Fatty Acids / Q000096:biosynthesis / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008297:Male; D010080:Oxazoles / Q000494:pharmacology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D051381:Rats; D013806:Theophylline / Q000037:antagonists & inhibitors; D014280:Triglycerides / Q000378:metabolism
D000963:Antimetabolites; D002247:Carbon Isotopes; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D010080:Oxazoles; D014280:Triglycerides; D002110:Caffeine; D013806:Theophylline; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D005947:Glucose
Hemmung der Lipolyse im Fettgewebe durch Methylisoxazolcarbonsäuren.